MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinson’s"

  • 2023 International Congress

    Sleep quality in GBA, LRRK2 and idiopathic Parkinson disease

    A. Yoo, R. Ortega, D. Raymond, B. Plitnick, M. Markgraf, J. Liang, M. Rawal, A. Wise, M. Pullman, K. Leaver, V. Katsnelson, J. Miravite, V. Shanker, M. Swan, M. Figueiro, S. Bressman, R. Saunders-Pullman (New York, USA)

    Objective: To describe sleep characteristics and quality in GBA, LRRK2 and non-genetic idiopathic Parkinson disease. Background: Sleep disturbances are one of the most common non-motor…
  • 2023 International Congress

    Correlation between hemoglobin level and disease severity in patients with Parkinson’s disease

    O. Gavriliuc, L. Rotaru, M. Gavriliuc, A. Caldarov (Chisinau, Republic of Moldova)

    Objective: Objective of this study was to investigate the potential correlation between hemoglobin levels and Parkinson's disease (PD) severity, and to compare them with a…
  • 2023 International Congress

    Piloting the Cats-and-Dogs tool as a culture-fair test for sensory processing impairment in Parkinson’s disease

    D. Mair, K. Dey, E. Camboe, A. Zirra, R. Weil, D. Gallagher, C. Budu, T. Haque, A. Noyce, C. Marshall, S. Waters (London, United Kingdom)

    Objective: This pilot explored the feasibility and culture-fairness of a psychophysical visuoperceptual test for Parkinson’s disease (PD) in a multicultural population in East London. Background:…
  • 2023 International Congress

    Recruitment of Parkinson’s disease patients with mild-to-moderate anxiety into a randomized controlled trial: Experience of a large Canadian tertiary movement disorders clinic

    J. Lam, J. Zhu, D. Meng, P. Uzelman, S. Appel-Cresswell (Vancouver, Canada)

    Objective: To report our experience of recruiting Parkinson’s disease (PD) patients with mild-to-moderate anxiety into a randomized controlled trial. Background: Anxiety is a common non-motor…
  • 2023 International Congress

    Inferring Rigidity Scores in MDS-UPDRS Motor Assessment from Other Items

    F. Duque Quiceno, Y. Dushin, G. Sarapata, S. Komarov, A. Matveev, J. O'Keeffe (London, United Kingdom)

    Objective: This study aimed to explore the possibility of inferring rigidity scores in MDS-UPDRS assessments from other items to enhance the accuracy of clinical evaluations…
  • 2023 International Congress

    Current practices for ‘timing’ of physical therapy in Parkinson’s Disease: ‘Burst vs. Spaced’

    J. Lelaurin, R. Salloum, M. Okun (Gainesville, USA)

    Objective: To assess current practices for timing of physical therapy (PT) in Parkinson’s disease (PD). Background: Most persons with Parkinson disease (PD) face increasing mobility…
  • 2023 International Congress

    Premenstrual worsening of UPDRS motor scale in women affected by Parkinson’s Disease

    A. Thomas, D. Calisi, M. de Rosa, P. Ajdinaj, S. Sensi, M. Onodrj (Chieti, Italy)

    Objective: The role of estrogen in dopaminergic pathways and the premenstrual worsening of parkinsonian symptoms. Background: Female sex hormones, during the menstrual cycle, could influence…
  • 2023 International Congress

    Characterization of at-home sleep macrostructure in Parkinson disease using a wearable sleep monitoring device

    J. Thompson, L. Hirt, D. Kern, A. Baumgartner (AURORA, USA)

    Objective: Determine the viability of a wearable reduced montage EEG device to record sleep in a population of patients with Parkinson disease (PD). Background: Sleep…
  • 2023 International Congress

    Obesity is a protective factor for the development of Parkinson’s disease in participants of the Framingham Heart Study Cohort

    S. O'Shea, Y. Liu, C. Liu, S. Frank, R. Au (New York, USA)

    Objective: To determine the role of obesity in the development of Parkinson's disease in a retrospective matched cohort study. Background: Parkinson’s disease (PD) is a…
  • 2023 International Congress

    The High Prevalence of Developmental Vascular Anomalies in Parkinson’s Disease using USPIO-based MICRO MRI

    S. Sharma, S. Buch, D. Reese, T. Wade, G. Prado Miranda, M. Haacke, C. Tzoulis, M. Jog (London, Canada)

    Objective: To improve cerebral vascular visibility using an ultra-small super-paramagnetic iron oxide (USPIO) contrast agent and identify vascular abnormalities in patients with Parkinson’s disease (PD).…
  • « Previous Page
  • 1
  • …
  • 235
  • 236
  • 237
  • 238
  • 239
  • …
  • 436
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley